StocksFin Logo
GBT logo
$GBT

Global Blood Therapeutics, Inc.

GBT country of incorporation
|
https://www.gbt.com
|
Dr. Ted Love
|
457 employees
NASDAQ | Healthcare | Biotechnology
GBT reported its Q222 earnings on August 8, 2022 (111 weeks ago).
$71.55M 50.5% vs. Q221 Revenues Q222
98.03% -0.4% vs. Q221 Gross Profit Margin
-115.26% ! 21.2% vs. Q221 Net Profit Margin
-44.69M ! 0.9% vs. Q221 Free Cash Flow Q222
$-1.26 ! -12.5% vs. Q221 EPS Q222
Company Card Q222
As reported on August 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q222
As reported on August 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q22022
71.55M
+29.7%
1.41M
-82.47M
-1.3%
$-1.26
Q12022
55.16M
1.06M
-81.42M
$-1.26
FY2021
194.75M
 3.32M
-303.09M
$-4.82
Q42021
56.1M
+7.8%
1.15M
-87.58M
-23.4%
$-1.36
Q32021
52.05M
+9.5%
830k
-70.99M
-2%
$-1.13
Q22021
47.56M
+21.8%
748k
-69.59M
+7.1%
$-1.12
Q12021
39.04M
584k
-74.93M
$-1.21
FY2020
123.8M
 1.99M
-247.55M
$-4.04
FY2019
2.11M
 48k
-266.77M
$-4.57
FY2018
0
 0
-174.19M
$-3.41
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q22022
870.44M
 752.08M
261.15M
658.39M
118.36M
Q12022
869.54M
 735.54M
391.8M
659.05M
134M
FY2021
939.21M
 742.8M
684.72M
665.29M
196.41M
FY2020
724M
 307.85M
494.77M
158.49M
416.16M
FY2019
796.1M
 217.41M
302.24M
77.29M
578.69M
FY2018
617.64M
 44.84M
275.36M
0
572.8M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q22022
-44.31M
 -134.66M
48.6M
-384k
-44.69M
+38%
Q12022
-71.85M
 -222.5M
1.6M
-252k
-72.11M
FY2021
-256.81M
 12.11M
434.34M
-3.23M
-260.05M
FY2020
-211.86M
 317.31M
87.12M
-8.75M
-220.62M
FY2019
-194.42M
 -76.86M
298.16M
-3.46M
-197.88M
FY2018
-135.38M
 -184.16M
397.91M
-4.82M
-140.2M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees